Literature DB >> 18070611

Downregulation of Par-3 expression and disruption of Par complex integrity by TGF-beta during the process of epithelial to mesenchymal transition in rat proximal epithelial cells.

Xiangyang Wang1, Jing Nie, Qin Zhou, Wei Liu, Fengxin Zhu, Wei Chen, Haiping Mao, Ning Luo, Xiuqing Dong, Xueqing Yu.   

Abstract

Epithelial to mesenchymal transition (EMT) is a fundamental mechanism of organ fibrosis and the initial step is disruption of cell junction and cell polarity. TGF-beta has been demonstrated as the most important mediator of EMT which is sufficient to initiate and complete the whole course of EMT, however, the detailed mechanism of TGF-beta in modulating the disruption of cell junction still remains unclear. Par-3 is a component of Par complex which plays a crucial role in the establishment and maintenance of epithelial polarity. In this study, we found that TGF-beta treatment resulted in a dose- and time-dependent downregulation of Par-3 protein together with the suppression of E-cadherin expression and induction of alpha-SMA. The decreased Par-3 subsequently resulted in the redistribution of Par-6-aPKC complex from cell membrane to cytoplasm. Forced expression of exogenous Par-3 into rat proximal epithelial cells (NRK52E) led to a drastic blockage of TGF-beta1-induced E-cadherin suppression and alpha-SMA induction. In contrast, knockdown Par-3 expression by siRNA significantly enhanced TGF-beta1-induced E-cadherin suppression and alpha-SMA induction. These data indicate that downregulation of Par-3 and subsequent disruption of Par complex integrity might be one mechanism that TGF-beta destroys cell polarity during EMT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070611     DOI: 10.1016/j.bbadis.2007.11.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

Review 1.  Lipid-based patterning of the immunological synapse.

Authors:  Morgan Huse
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

Review 2.  Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Authors:  Nathan J Godde; Ryan C Galea; Imogen A Elsum; Patrick O Humbert
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-12       Impact factor: 2.673

Review 3.  Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment.

Authors:  Danila Coradini; Claudia Casarsa; Saro Oriana
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

Review 4.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

5.  Expressions of connexin and par-3 in the distal margin of rectal cancer after ultra-low anterior resection.

Authors:  Jun Liu; Weikang Zhang; Jinlin Liu; Xiaoming Lu; Yaoping Long; Yancai Zhou; Shenghong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

Review 6.  Mechanisms of polarity protein expression control.

Authors:  Syed Mukhtar Ahmed; Ian G Macara
Journal:  Curr Opin Cell Biol       Date:  2016-04-16       Impact factor: 8.382

Review 7.  Polarity proteins and cell-cell interactions in the testis.

Authors:  Elissa W P Wong; C Yan Cheng
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

Review 8.  New insights of epithelial-mesenchymal transition in cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

Review 9.  Apico-basal polarity complex and cancer.

Authors:  Mohammed Khursheed; Murali Dharan Bashyam
Journal:  J Biosci       Date:  2014-03       Impact factor: 1.826

10.  Numb regulates cell-cell adhesion and polarity in response to tyrosine kinase signalling.

Authors:  Zezhou Wang; Shelley Sandiford; Chenggang Wu; Shawn Shun-Cheng Li
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.